People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SARcode Corp | — | Biotechnology | Series C | $99.6M | $1.8B | 2011 |
Charles Semba at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Semba on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Alexander | 1 | 6 |
| DENNIS HENNER | 1 | 5 |
| Emmett Cunningham | 1 | 4 |
| Dan Janney | 1 | 4 |
| Thomas Gadek | 1 | 3 |
| Quinton Oswald | 1 | 3 |
| Garheng A. Kong | 1 | 2 |
| Todd A Creech | 1 | 1 |
| Mary A Newman | 1 | 1 |
| Martin A Vogelbaum | 1 | 1 |
| Valerie A Smith | 1 | 1 |
| John Burnier | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.